Skip to main content

Polymyxin B/Trimethoprim Ophthalmic Dosage

Medically reviewed by Drugs.com. Last updated on Jan 24, 2024.

Applies to the following strengths: 10000 units-1 mg/mL

Usual Adult Dose for Bacterial Conjunctivitis

Instill 1 drop in the affected eye(s) every 3 hours for 7 to 10 days.
Maximum dose: 6 doses/day

Uses: For the treatment of mild to moderate surface ocular bacterial infections (including acute bacterial conjunctivitis) and blepharoconjunctivitis due to susceptible strains of Staphylococcus aureus, S epidermidis, Streptococcus pneumoniae, viridans streptococci, Haemophilus influenzae, Pseudomonas aeruginosa

Usual Adult Dose for Blepharoconjunctivitis

Instill 1 drop in the affected eye(s) every 3 hours for 7 to 10 days.
Maximum dose: 6 doses/day

Uses: For the treatment of mild to moderate surface ocular bacterial infections (including acute bacterial conjunctivitis) and blepharoconjunctivitis due to susceptible strains of Staphylococcus aureus, S epidermidis, Streptococcus pneumoniae, viridans streptococci, Haemophilus influenzae, Pseudomonas aeruginosa

Usual Pediatric Dose for Bacterial Conjunctivitis

2 months or older: Instill 1 drop in the affected eye(s) every 3 hours for 7 to 10 days.
Maximum dose: 6 doses/day

Uses: For the treatment of mild to moderate surface ocular bacterial infections (including acute bacterial conjunctivitis) and blepharoconjunctivitis due to susceptible strains of S aureus, S epidermidis, S pneumoniae, viridans streptococci, H influenzae, P aeruginosa

Usual Pediatric Dose for Blepharoconjunctivitis

2 months or older: Instill 1 drop in the affected eye(s) every 3 hours for 7 to 10 days.
Maximum dose: 6 doses/day

Uses: For the treatment of mild to moderate surface ocular bacterial infections (including acute bacterial conjunctivitis) and blepharoconjunctivitis due to susceptible strains of S aureus, S epidermidis, S pneumoniae, viridans streptococci, H influenzae, P aeruginosa

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:
Known hypersensitivity to either active component or to any of the ingredients

Safety and efficacy have not been established in patients younger than 2 months.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.